Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalfampridine and Locomotor Training in Chronic Motor Incomplete SCI
NCT01621113Phase 2Completed
- Sponsor
- Kessler Foundation
- Start
- Jun 2012
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dalfampridine in spinal cord injury (SCI), sponsored by Kessler Foundation. Started Jun 2012; status: completed.
02
Drugs
dalfampridine
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on NCT01621113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01621113.